Orthofix
ProfileJobs

Orthofix

Suggest Edit
    • Healthclinics

    Headquartered in Lewisville, TX, the company has four strategic business units that include BioStim, Biologics, Extremity Fixation and Spine Fixation. Our products are distributed in more than 70 countries around the world via Orthofix sales representatives, distributors and subsidiaries.

    Founded in Verona, Italy in 1980, Orthofix has approximately 900 employees around the world who are dedicated to the development, manufacturing and distribution of orthopedic and spine products and regenerative tissue forms. Many of our innovative product offerings were cultivated through affiliations with surgeons and premiere health care organizations. Orthofix is proud to collaborate on research and development activities with leading clinical organizations such as the Musculoskeletal Transplant Foundation (MTF) and the Texas Scottish Rite Hospital for Children.

    Revenue(FY, 2017)
    $433.8 M
    Market capitalization(2018-06-22)
    $1.1 B
    Type
    Public
    HQ
    Z.a.i., IT
    Founded
    1980
    Size (employees)
    938 (est)
    Website
    orthofix.com
    Orthofix was founded in 1980 and is headquartered in Z.a.i., IT
    Report incorrect company information

    Key People/Management at Orthofix

    Brad Mason

    Brad Mason

    President and Chief Executive Officer
    Doug Rice

    Doug Rice

    Chief Financial Officer ​
    Kimberley Elting

    Kimberley Elting

    Chief Legal and Administrative Officer
    Jill Mason

    Jill Mason

    ​ Chief Ethics and Compliance Officer​
    Jim Ryaby

    Jim Ryaby

    ​ Chief Scientific Officer​
    Tim McGuire

    Tim McGuire

    ​Chi​ef Information Officer​
    Show more

    Orthofix Office Locations

    Orthofix has offices in Willemstad, Z.a.i., Sona, São Paulo and in 5 other locations
    Z.a.i., IT (HQ)
    9 Via delle Nazioni
    Sona, IT
    7 Via della Filanda
    São Paulo, BR
    1212 R. Alves Guimarães
    Willemstad, CW
    A. de Veerstraat
    Arcueil, FR
    28 Villa Baudran
    Ottobrunn, DE
    5 Siemensstraße
    Show all (9)
    Report incorrect company information

    Orthofix Financials and Metrics

    Orthofix Financials

    Orthofix's revenue was reported to be $433.82 m in FY, 2017
    USD

    Revenue (Q1, 2018)

    		108.7 m

    Gross profit (Q1, 2018)

    		84.6 m

    Gross profit margin (Q1, 2018), %

    		77.8%

    Net income (Q1, 2018)

    		5.2 m

    EBIT (Q1, 2018)

    		7.9 m

    Market capitalization (22-Jun-2018)

    		1.1 b

    Closing share price (22-Jun-2018)

    		60.1

    Cash (31-Mar-2018)

    		77.1 m
    Orthofix's current market capitalization is $1.1 b.
    Annual
    USDFY, 2016FY, 2017

    Revenue

    		409.8 m433.8 m

    Cost of goods sold

    		87.9 m93 m

    Gross profit

    		321.9 m340.8 m

    Gross profit Margin, %

    		79%79%
    Quarterly
    USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

    Revenue

    		101 m101 m89.8 m101 m101.2 m98.7 m104.1 m98.5 m102.7 m108.7 m

    Cost of goods sold

    		25.4 m25.3 m19.3 m21.9 m23.9 m22.1 m22.5 m19.9 m22.6 m24.1 m

    Gross profit

    		75.6 m75.7 m70.4 m79 m77.3 m76.5 m81.6 m78.6 m80.2 m84.6 m

    Gross profit Margin, %

    		75%75%78%78%76%78%78%80%78%78%
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Cash

    		30.5 m36.8 m63.7 m39.6 m81.2 m

    Accounts Receivable

    		2.8 m

    Inventories

    		90.6 m59.8 m57.6 m63.3 m81.3 m

    Current Assets

    		280.2 m256.4 m212.3 m194.4 m251.8 m
    Quarterly
    USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

    Cash

    		28.9 m29.8 m29.8 m55.9 m63.7 m39.8 m40.5 m46.8 m41.7 m77.1 m

    Inventories

    		70.9 m64.3 m56.7 m59.2 m57.8 m59.8 m61.3 m65 m66.3 m77.7 m

    Current Assets

    		292.7 m270.3 m235 m235.2 m245.5 m174 m178 m185.2 m186.8 m263.1 m

    PP&E

    		51.1 m49.6 m46.7 m50 m51.5 m53.6 m52.5 m51.9 m48 m44 m
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Net Income

    		(25.5 m)(8.5 m)(2.8 m)3.1 m6.2 m

    Depreciation and Amortization

    		2.3 m20.9 m20.8 m20.1 m

    Inventories

    		(6.6 m)8.1 m3.1 m(5.3 m)(15.6 m)

    Accounts Payable

    		(2.3 m)(6.5 m)3 m(1.8 m)2.3 m
    Quarterly
    USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

    Net Income

    		(683 k)452 k(8.4 m)3.6 m(1.4 m)3.9 m(7.4 m)9.9 m(2.7 m)5.2 m

    Depreciation and Amortization

    		661 k508 k405 k4.4 m

    Inventories

    		70.9 m64.3 m56.7 m59.2 m57.8 m59.8 m61.3 m65 m66.3 m1.7 m

    Accounts Payable

    		15.7 m13.2 m16.3 m17.2 m17 m13.5 m13.7 m14.4 m16.6 m(4.5 m)
    show all
    USDY, 2018

    Financial Leverage

    		1.3 x
    Show all financial metrics
    Report incorrect company information

    Competitors

    Zimmer Biomet
    Health - Public
    Hanger
    Health - Public
    Advanced Oncotherapy
    Health - Public
    Fusion Antibodies
    Health - Private
    Compare competitors

    Orthofix Online and Social Media Presence

    Embed Graph
    Report incorrect company information

    Orthofix News and Updates

    April 30, 2018

    Orthofix International's (OFIX) CEO Brad Mason on Q1 2018 Results - Earnings Call Transcript

    January 23, 2018

    Spinal Fusion Market with Current Trends Analysis 2021

    Spinal fusion is a surgical procedure to fuse two or more vertebrae to restrict their movement. The procedure is recommended to eliminate the pain caused by incorrect movement of vertebrae. Posted via Industry Today. Follow us on Twitter @IndustryToday
    November 21, 2017

    Electromagnetic Therapy Device Market: Global Industry Analysis and Opportunity and Forecast 2017 to 2023

    Electromagnetic Therapy Device Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday
    September 15, 2017

    Bone Screw System Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

    The key factor that is contributing to the growth of the bone screw systems market is the rise in the number of people that are suffering from trauma and orthopedic diseases. Posted via Industry Today. Follow us on Twitter @IndustryToday
    August 17, 2017

    Bone Growth Stimulators Market to Account for US$ 2,502.0 Mn by 2025 end

    Future Market Insights has announced the addition of the “Bone Growth Stimulators Market: Global Industry Analysis and Opportunity Assessment, 2015-2025"report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday
    Report incorrect company information
    Download PDF